Sponsor Pipeline

Ocular Therapeutix, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
4
Phase 3
Active Trials by Phase
Phase 3
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07235085 A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants… Non-Proliferative Diabetic Retinopathy Recruiting
NCT07516132 Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in… Neovascular Age-Related Macular Degeneration (nAMD) Recruiting
NCT06223958 Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix)… Neovascular Age-Related Macular Degeneration Active, Not Recruiting
NCT06495918 Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in… Neovascular Age-related Macular Degeneration Active, Not Recruiting
Get alerts when Ocular Therapeutix, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free